Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53.
Journal: The Journal of biological chemistry
Published: November 04, 2025
Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 02, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer.
Journal: JCI insight
Published: October 14, 2024
Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 23, 2024
KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
Journal: Cancer research communications
Published: October 25, 2023
GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1.
GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: August 23, 2022
SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer.
Journal: The Biochemical journal
Published: August 21, 2022
Last Updated: 09/26/2026